You are here

liposarcoma

Rain Oncology is latest troubled biotech to receive acquisition offer from Concentra

Fierce Biotech

Mon, 10/16/23 - 11:37 pm

Concerta Biosciences

Rain Oncology Plummets after Lead Candidate Disappoints in Phase 3

Tip Ranks

Wed, 05/24/23 - 10:14 am

clinical trials

Rain Targets Normal p53 Expression with Possible Pan-Cancer Therapeutic

BioSpace

Tue, 06/21/22 - 10:56 am

Rain Therapeutics

clinical trials